Category - Pharmaceuticals Market Research Report

Voice/Vocal Biomarker Market Size, Share & Trends Analysis Distribution by Platform Type (Cloud-based and Web-based), Indication Type (Respiratory Diseases, Neurological Disorder, Cardiovascular Disease, Mental Health Disorder, and Others), Application (Diagnostics, Clinical Research, Monitoring, and Others), End User (Hospitals, Research Institutions, and CROs), and Segment Forecasts, 2025-2034

Global Voice/Vocal Biomarker Market Size is valued at US$ 1.1 Bn in 2024 and is predicted to reach US$ 4.2 Bn by the year 2034 at an 14.2% CAGR during the forecast period for 2025-2034. The Voice/Vocal Biomarker is a method that analyses, records, and locates unprocessed speech sounds, enabling machines to recognise and understand human emotions. Anxiety, depression, and atherosclerotic coronary heart disease are among the conditions linked to b...

Report ID: 3214 |

Delivery: Immediate |

Published: October 2025 |

No. of Pages: 180

HIV Drugs Market Size, Share & Trends Analysis Report By Drug Type (Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Protease Inhibitors (PIs), Integrase Inhibitors, Entry and Fusion Inhibitors, Combination Class Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, And Segment Forecasts, 2025-2034

HIV Drugs Market Size is valued at 39.29 Billion in 2024 and is predicted to reach 59.74 Billion by the year 2034 at a 4.4% CAGR during the forecast period for 2025-2034. Acquired immunodeficiency syndrome (AIDS) is caused by the human immunodeficiency virus (HIV). The virus damages the immune system and thus interferes with the body’s ability to fight organisms that cause disease. HIV attacks immune cells, specifically CD-4 cells,...

Report ID: 1092 |

Delivery: Immediate |

Published: October 2025 |

No. of Pages: 170

Molecular Pharming Market Size, Share & Trends Analysis Report By Technology (Gene Gun, Agroinfiltration, Electroporation, Agrobacterium-Mediated Gene Transfer), By Application (Recombinant Antibodies, Hormones, Vaccines, Industrial Enzymes, Proteins & Protein-Based Materials, Technical Reagents, Nutritional Products), By Crop Source, By End User, By Region, And Segment Forecasts, 2025-2034

Molecular Pharming Market Size is valued at USD 1655.3 Mn in 2023 and is predicted to reach USD 3516.73 Mn by the year 2034 at a 8.1% CAGR during the forecast period for 2025-2034. In a biotechnological program known as "molecular farming," crops are genetically altered to create proteins and chemicals for industrial and pharmaceutical uses. The vast majority of developing nations cannot pay the enormous price of medical treatment...

Report ID: 1712 |

Delivery: Immediate |

Published: October 2025 |

No. of Pages: 180

NAD-based Anti-Aging Market Size, Share & Trends Analysis Report By Precursor, By Product Type (Supplements (Oral NAD Dietary Supplements, Topical NAD Supplements (Creams, Serums, Lip Creams, Eye Creams)) Therapeutic Products (NAD Nasal Spray, and NAD injections/NAD IV)), Type of Aging, Distribution Channel, Region, And Segment Forecasts, 2025-2034

Global NAD-based Anti-Aging Market is valued at USD 252.0 Million in 2024 and is predicted to reach USD 884.0 Million by the year 2034 at a 13.5% CAGR during the forecast period for 2025-2034. Nicotinamide adenine dinucleotide is crucial in all essential biological activities. When produced naturally, NAD+ may help to increase DNA damage repair, improve cognitive function, boost oxidative stress resistance, reduce inflammatio...

Report ID: 2284 |

Delivery: Immediate |